Novel Applications of Oligo(Carbamoylated Guanidine) Compositions
Legal Citation
Summary of the Inventive Concept
This inventive concept explores new applications of oligo(carbamoylated guanidine) compositions beyond tuberculosis treatment, leveraging their antimicrobial properties to address unmet needs in agriculture, industry, personal care, food preservation, and biocidal coatings.
Background and Problem Solved
The original patent disclosed oligo(carbamoylated guanidine) compositions as anti-mycobacterial drugs for tuberculosis treatment. However, the antimicrobial properties of these compositions have broader potential. The inventive concept addresses the limitations of existing solutions in various industries, including agricultural crop protection, industrial water system maintenance, personal care product development, food preservation, and biocidal coatings.
Detailed Description of the Inventive Concept
The new claims describe novel applications of oligo(carbamoylated guanidine) compositions in different industries. Claim 1 proposes a method for treating fungal infections in agricultural crops using a controlled-release composition. Claim 2 describes a system for controlling fungal growth in industrial water systems. Claim 3 presents a personal care product with antimicrobial properties against skin-borne pathogens. Claim 4 outlines a method for preserving food products by applying an oligo(carbamoylated guanidine) coating. Claim 5 introduces a biocidal paint composition inhibiting microorganism growth on painted surfaces. These applications leverage the antimicrobial properties of oligo(carbamoylated guanidine) compositions to provide innovative solutions.
Novelty and Inventive Step
The novelty of this inventive concept lies in the unexpected application of oligo(carbamoylated guanidine) compositions to new industries and use cases, demonstrating a non-obvious extension of their antimicrobial properties beyond tuberculosis treatment.
Alternative Embodiments and Variations
Alternative embodiments may include varying the composition's structure, modifying the delivery mechanism, or combining the oligo(carbamoylated guanidine) with other antimicrobial agents. Variations may also involve adapting the composition for use in different environmental conditions or against specific microorganisms.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including agriculture, industry, personal care, food preservation, and biocidal coatings. The target market includes companies developing innovative solutions for crop protection, industrial water system maintenance, personal care product development, food preservation, and biocidal coatings.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K31/17 |
| A | A61 | A61K31/133 |
| A | A61 | A61K31/277 |
| A | A61 | A61K31/4409 |
| A | A61 | A61K31/47 |
| A | A61 | A61K31/496 |
| A | A61 | A61K31/498 |
| A | A61 | A61K31/4965 |
| A | A61 | A61K31/5377 |
| A | A61 | A61P31/06 |
| C | C07 | C07C279/12 |
| C | C07 | C07D295/215 |
| C | C08 | C08G65/00 |
| C | C08 | C08G71/02 |
| C | C07 | C07C2601/16 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical chemistry and antimicrobial composition design, with expertise in synthetic organic chemistry, drug delivery systems, and microbial control technologies across medical, agricultural, and industrial applications
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degree in chemistry or chemical engineering, familiar with antimicrobial compound design, structure-activity relationships, and cross-industry applications of bioactive molecules
Obviousness Rationale
A person skilled in the art would recognize the inherent antimicrobial properties of oligo(carbamoylated guanidine) compounds and understand their potential for broad-spectrum applications beyond tuberculosis treatment. The structural flexibility and proven antimicrobial mechanism disclosed in the source patent naturally suggest adaptability to diverse microbiological control scenarios. Given the compound's demonstrated efficacy against mycobacteria, a skilled practitioner would readily contemplate extending its use to other microbial control contexts using standard formulation and delivery techniques.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,521 |
|---|---|
| Title | Anti-mycobacterial drugs |
| Assignee(s) | The Florida International University Board of Trustees |